IXP Launches INR 200 Cr Fund to Boost Biotech Innovation The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals, agrotechnology, and nutraceuticals.

By BIZ Experiences Staff

You're reading BIZ Experiences India, an international franchise of BIZ Experiences Media.

[L-R] Vishal Goel (Partner at IXP and Co-founder of JV Ventures), Dr Ketki Tulpule (CIO at IXP), & Jasmeet Chhabra (Partner at IXP)

IXP, a lifesciences-focused venture capital firm backed by JV Ventures, has announced the launch of its maiden fund, the IXP Lifesciences Catalyst Fund. Targeting a corpus of INR 200 crore, with a greenshoe option of INR 100 crore, the fund aims to support early-stage biotech companies in India.

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals, agrotechnology, and nutraceuticals.

Dr Ketki Tulpule, CIO at IXP, highlighted the fund's unique approach: "We identified a critical gap in the Indian startup ecosystem for biotech. Our pan-India survey revealed challenges requiring specialised expertise. With industry veterans as advisors, we bring scientific, operational, and industry-specific support to our investments."

IXP adopts a hands-on investment model through its Venture Studio, co-creating startups with scientists to address unmet market needs. Vishal Goel, Partner at IXP and Co-founder of JV Ventures, stated, "Unlike traditional VCs, we actively participate from concept to scale, transforming scientists into founders through our Venturepreneur Program."

Further differentiating itself, IXP leverages PoweRx, the lifesciences vertical of JV Ventures, to provide portfolio companies with access to laboratories, R&D services, and networks. Jasmeet Chhabra, Partner at IXP, explained, "Early-stage biotech companies need more than just funding. Our ecosystem ensures they have the resources to succeed."

With this fund, IXP aims to catalyse innovation in India's dynamic lifesciences sector, creating a robust ecosystem for scientific BIZ Experiencesship. Through its strategic approach, IXP is poised to unlock the untapped potential of the biotech industry while fostering transformative breakthroughs.
BIZ Experiences Staff

BIZ Experiences Staff

Editor

For more than 30 years, BIZ Experiences has set the course for success for millions of BIZ Experiencess and small business owners. We'll teach you the secrets of the winners and give you exactly what you need to lay the groundwork for success.

Most Popular

See all
Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for BIZ Experiencess to pursue in 2025.

By Eve Gumpel
Growing a Business

Forget Investors and Co-Founders — Here's How I Built a Lean, Scalable Business on My Terms

You don't need a partner or investors to build something that lasts. You need vision, systems and the guts to go all in on yourself. Here's how I built alone — and why I still would, even now.

By Sarah Choudhary
Growing a Business

10 Habits That Separate Rich and Successful Founders From Wannabe BIZ Experiencess

Successful BIZ Experiencess adopt rich habits. Unsuccessful BIZ Experiencess ignore their habits.

By Tom Corley
Science & Technology

OpenAI's Latest Move Is a Game Changer — Here's How Smart Solopreneurs Are Turning It Into Profit

OpenAI's latest AI tool acts like a full-time assistant, helping solopreneurs save time, find leads and grow their business without hiring.

By Ben Angel
Business News

Here's How Much Google Software Engineers, Product Managers, and Data Scientists Make in a Year

Data revealed in federal filings shows how much Google is compensating its employees.

By Sherin Shibu
Science & Technology

AI Isn't Plug-and-Play — You Need a Strategy. Here's Your Guide to Building One.

Don't just "add AI" — build a strategy. This guide helps founders avoid common pitfalls and create a step-by-step roadmap to harness real value from AI.

By Nicholas Leighton